Medrogestone (INN), also known as 6,17α-dimethyl-6-dehydroprogesterone, is a progestational agent derived from 17-methylprogesterone. It was conceived as an alternative for an orally effective contraceptive option. It was developed by Ayerst, approved in Canada in 1969 and its current status is cancelled post-marketing. It was never approved by the FDA. It is grouped under the following drug class(es): Progestins. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Medrogesterone and Colprone. Its PubChem CID is 9949848.
Medrogestone
| CAS No | 977-79-7 |
|---|---|
| Molecular Formula | C23H32O2 |
| Molecular Weight | 340.5 g/mol |
| Synonyms | (8R,9S,10R,13S,14S,17S)-17-acetyl-6,10,13,17-tetramethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Medrogestone (INN), also known as 6,17α-dimethyl-6-dehydroprogesterone, is a progestational agent derived from 17-methylprogesterone. It was conceived as an alternative for an orally effective contraceptive option.
The listed CAS number is 977-79-7.
The listed molecular formula is C23H32O2.
The listed molecular weight is 340.5 g/mol.
(8R,9S,10R,13S,14S,17S)-17-acetyl-6,10,13,17-tetramethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one.
The source lists Medrogesterone and Colprone.